145720.Ks
The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
Business. The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
Analyst recommendations
6 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
The company maintains a debt-to-equity ratio of 0.51, indicating a moderate level of leverage, and a current ratio of 1.44, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's free cash flow is negative at -17,726,842,100 KRW, and capital expenditures are substantial at -53,556,019,040 KRW, which may signal reinvestment in operations or asset expansion.
In terms of profitability, the company's return on equity is 2.92%, and return on assets is 1.76%, both of which are below the industry median for the Medical Equipment, Supplies & Distribution sector. This suggests the company is underperforming its peers in terms of generating returns from equity and total assets.
The company's revenue is concentrated in a single business segment, as disclosed in its financials, with no geographic diversification provided in the available data. This lack of segment and geographic diversification could expose the company to higher operational and market risks.
Looking ahead, the company's revenue is expected to grow, though the exact rate is not specified. The capital expenditure of -53,556,019,040 KRW indicates a significant investment in infrastructure or expansion, which may support future revenue growth.
The company faces a medium liquidity risk, as indicated by its negative net cash position after subtracting total debt. The risk of dilution is assessed as low, with no significant dilution events reported in the recent financial data.
Recent filings and transcripts do not provide specific details on new product launches or strategic partnerships. However, the company's operating cash flow of 13,239,357,610 KRW suggests it is generating positive cash from operations, which is a positive sign for its financial health.
- The company has a moderate level of leverage with a debt-to-equity ratio of 0.51.
- The company's return on equity and return on assets are below the industry median, indicating underperformance in profitability.
- The company's free cash flow is negative, and capital expenditures are significant, suggesting reinvestment in operations or asset expansion.
- The company's liquidity risk is medium, and the risk of dilution is low.
- The company's operating cash flow is positive, indicating it is generating cash from operations.
- "margin_outlook_rationale": "The company's gross profit margin is expected to remain stable, driven by consistent demand for medical equipment and supplies.",
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 6 446,00 |
| Revenue | —no estimate | —no estimate | 403,2B KRW |
| Operating income | —no estimate | —no estimate | 83,5B KRW |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- 145720.KS Market data — financials · 2026-05-26
- Dentium Co Ltd Market data — analyst estimates · 2026-05-26